BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35788405)

  • 21. [Medical treatment of chylous effusions in newborn infants. Apropos of 3 cases].
    Jernite M; Donato L; Favre R; Haddad J; Esposito M; Messer J
    Arch Fr Pediatr; 1992 Nov; 49(9):811-4. PubMed ID: 1300971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chylothorax in cirrhosis of the liver: analysis of its frequency and clinical characteristics.
    Romero S; Martín C; Hernandez L; Verdu J; Trigo C; Perez-Mateo M; Alemany L
    Chest; 1998 Jul; 114(1):154-9. PubMed ID: 9674463
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An updated patent review of rearranged during transfection (RET) kinase inhibitors (2016-present).
    Acharya B; Frett B
    Expert Opin Ther Pat; 2022 Oct; 32(10):1067-1077. PubMed ID: 36198171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overcoming MET-Dependent Resistance to Selective RET Inhibition in Patients with RET Fusion-Positive Lung Cancer by Combining Selpercatinib with Crizotinib.
    Rosen EY; Johnson ML; Clifford SE; Somwar R; Kherani JF; Son J; Bertram AA; Davare MA; Gladstone E; Ivanova EV; Henry DN; Kelley EM; Lin M; Milan MSD; Nair BC; Olek EA; Scanlon JE; Vojnic M; Ebata K; Hechtman JF; Li BT; Sholl LM; Taylor BS; Ladanyi M; Jänne PA; Rothenberg SM; Drilon A; Oxnard GR
    Clin Cancer Res; 2021 Jan; 27(1):34-42. PubMed ID: 33082208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of
    Jaleel J; Nasurudeen S; Babu AS; Gupta P; Khangembam BC; Patel C; Kumar R
    Nucl Med Mol Imaging; 2023 Dec; 57(6):265-274. PubMed ID: 37982099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contrast-enhanced Interstitial Transpedal MR Lymphangiography for Thoracic Chylous Effusions.
    Pieper CC; Feisst A; Schild HH
    Radiology; 2020 May; 295(2):458-466. PubMed ID: 32208098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting RET Solvent-Front Mutants with Alkynyl Nicotinamide-Based Inhibitors.
    Khatri U; Dayal N; Hu X; Larocque E; Naganna N; Shen T; Liu X; Holtsberg FW; Aman MJ; Sintim HO; Wu J
    Mol Cancer Ther; 2023 Jun; 22(6):717-725. PubMed ID: 37070927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive molecular pathology in metastatic thyroid cancer: the role of
    Nacchio M; Pisapia P; Pepe F; Russo G; Vigliar E; Porcelli T; Luongo C; Iaccarino A; Pagni F; Salvatore D; Troncone G; Malapelle U; Bellevicine C
    Expert Rev Endocrinol Metab; 2022 Mar; 17(2):167-178. PubMed ID: 35404189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nontraumatic Chylothorax and Chylopericardium: Diagnosis and Treatment Using an Algorithmic Approach Based on Novel Lymphatic Imaging.
    Gurevich A; Hur S; Singhal S; DiBardino D; Haas AR; Hansen-Flaschen JH; Nadolski G; Itkin M
    Ann Am Thorac Soc; 2022 May; 19(5):756-762. PubMed ID: 34797746
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapeutic effectiveness of diagnostic lymphangiography for refractory postoperative chylothorax and chylous ascites: correlation with radiologic findings and preceding medical treatment.
    Kawasaki R; Sugimoto K; Fujii M; Miyamoto N; Okada T; Yamaguchi M; Sugimura K
    AJR Am J Roentgenol; 2013 Sep; 201(3):659-66. PubMed ID: 23971461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of symptomatic primary chylous disorders.
    Noel AA; Gloviczki P; Bender CE; Whitley D; Stanson AW; Deschamps C
    J Vasc Surg; 2001 Nov; 34(5):785-91. PubMed ID: 11700476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphatic interventions for isolated, iatrogenic chylous ascites: A multi-institution experience.
    Majdalany BS; Khayat M; Downing T; Killoran TP; El-Haddad G; Khaja MS; Saad WA
    Eur J Radiol; 2018 Dec; 109():41-47. PubMed ID: 30527310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pralsetinib in RET fusion-positive non-small-cell lung cancer: A real-world data (RWD) analysis from the Italian expanded access program (EAP).
    Passaro A; Russo GL; Passiglia F; D'Arcangelo M; Sbrana A; Russano M; Bonanno L; Giusti R; Metro G; Bertolini F; Grisanti S; Carta A; Cecere F; Montrone M; Massa G; Perrone F; Simionato F; Guaitoli G; Scotti V; Genova C; Lugini A; Bonomi L; Attili I; de Marinis F
    Lung Cancer; 2022 Dec; 174():118-124. PubMed ID: 36379124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endolymphatic Interventions for the Treatment of Chylothorax and Chylous Ascites in Neonates: Technical and Clinical Success and Complications.
    Srinivasa RN; Chick JFB; Gemmete JJ; Hage AN; Srinivasa RN
    Ann Vasc Surg; 2018 Jul; 50():269-274. PubMed ID: 29524461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chylous effusions].
    Tomić I; Plavec G; Karlicić V; Spasić V; Rusović S; Stanić V; Cvijanović V; Ristanović A
    Vojnosanit Pregl; 2003; 60(5):613-20. PubMed ID: 14608841
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Advanced Non-Small Cell Lung Cancer with RET Fusions: Reality and Hopes.
    Rocco D; Sapio L; Della Gravara L; Naviglio S; Gridelli C
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sirolimus ameliorated post lung transplant chylothorax in lymphangioleiomyomatosis.
    Ohara T; Oto T; Miyoshi K; Tao H; Yamane M; Toyooka S; Okazaki M; Date H; Sano Y
    Ann Thorac Surg; 2008 Dec; 86(6):e7-8. PubMed ID: 19021963
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial.
    Subbiah V; Wolf J; Konda B; Kang H; Spira A; Weiss J; Takeda M; Ohe Y; Khan S; Ohashi K; Soldatenkova V; Szymczak S; Sullivan L; Wright J; Drilon A
    Lancet Oncol; 2022 Oct; 23(10):1261-1273. PubMed ID: 36108661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MRI Assessment of Chylous and Nonchylous Effusions: Use of Multipoint Dixon Fat Quantification.
    Kuetting D; Luetkens J; Fimmers R; Sprinkart AM; Attenberger U; Pieper CC
    Radiology; 2020 Sep; 296(3):698-705. PubMed ID: 32662762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interstitial Transpedal MR-Lymphangiography of Central Lymphatics Using a Standard MR Contrast Agent: Feasibility and Initial Results in Patients with Chylous Effusions.
    Pieper CC; Schild HH
    Rofo; 2018 Oct; 190(10):938-945. PubMed ID: 29665587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.